| Antibody structure, instability, and formulation W Wang, S Singh, DL Zeng, K King, S Nema Journal of pharmaceutical sciences 96 (1), 1-26, 2007 | 1293 | 2007 |
| Macrophages facilitate electrical conduction in the heart M Hulsmans, S Clauss, L Xiao, AD Aguirre, KR King, A Hanley, ... Cell 169 (3), 510-522. e20, 2017 | 952 | 2017 |
| Multilayer device for tissue engineering JT Borenstein, KR King, H Terai, JP Vacanti US Patent 7,371,400, 2008 | 657 | 2008 |
| IRF3 and type I interferons fuel a fatal response to myocardial infarction KR King, AD Aguirre, YX Ye, Y Sun, JD Roh, RP Ng Jr, RH Kohler, ... Nature medicine 23 (12), 1481-1487, 2017 | 504 | 2017 |
| Microfabrication technology for vascularized tissue engineering JT Borenstein, H Terai, KR King, EJ Weinberg, MR Kaazempur-Mofrad, ... Biomedical microdevices 4, 167-175, 2002 | 495 | 2002 |
| Immunogenicity of protein aggregates—concerns and realities W Wang, SK Singh, N Li, MR Toler, KR King, S Nema International journal of pharmaceutics 431 (1-2), 1-11, 2012 | 302 | 2012 |
| A high-throughput microfluidic real-time gene expression living cell array KR King, S Wang, D Irimia, A Jayaraman, M Toner, ML Yarmush Lab on a Chip 7 (1), 77-85, 2007 | 294 | 2007 |
| Biodegradable microfluidics KR King, CCJ Wang, MR Kaazempur-Mofrad, JP Vacanti, JT Borenstein Advanced Materials 16 (22), 2007-2012, 2004 | 252 | 2004 |
| Myocardial infarction activates CCR2+ hematopoietic stem and progenitor cells P Dutta, HB Sager, KR Stengel, K Naxerova, G Courties, B Saez, ... Cell stem cell 16 (5), 477-487, 2015 | 230 | 2015 |
| Dynamic gene expression profiling using a microfabricated living cell array DM Thompson, KR King, KJ Wieder, M Toner, ML Yarmush, A Jayaraman Analytical chemistry 76 (14), 4098-4103, 2004 | 200 | 2004 |
| Tissue-specific macrophage responses to remote injury impact the outcome of subsequent local immune challenge FF Hoyer, K Naxerova, MJ Schloss, M Hulsmans, AV Nair, P Dutta, ... Immunity 51 (5), 899-914. e7, 2019 | 157 | 2019 |
| Living-cell microarrays ML Yarmush, KR King Annual review of biomedical engineering 11 (1), 235-257, 2009 | 156 | 2009 |
| Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure SJ Patel, JM Milwid, KR King, S Bohr, A Iracheta-Vellve, M Li, A Vitalo, ... Nature biotechnology 30 (2), 179-183, 2012 | 145 | 2012 |
| Protective role of cross-reactive CD8 T cells against dengue virus infection AE Ngono, HW Chen, WW Tang, Y Joo, K King, D Weiskopf, J Sidney, ... EBioMedicine 13, 284-293, 2016 | 111 | 2016 |
| Microfluidic flow-encoded switching for parallel control of dynamic cellular microenvironments KR King, S Wang, A Jayaraman, ML Yarmush, M Toner Lab on a Chip 8 (1), 107-116, 2008 | 110 | 2008 |
| DNA-triggered innate immune responses are propagated by gap junction communication SJ Patel, KR King, M Casali, ML Yarmush Proceedings of the National Academy of Sciences 106 (31), 12867-12872, 2009 | 79 | 2009 |
| The myeloid type I interferon response to myocardial infarction begins in bone marrow and is regulated by Nrf2-activated macrophages DM Calcagno, RP Ng Jr, A Toomu, C Zhang, K Huang, AD Aguirre, ... Science immunology 5 (51), eaaz1974, 2020 | 76 | 2020 |
| Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation J Luther, S Khan, MK Gala, D Kedrin, G Sridharan, RP Goodman, ... Proceedings of the National Academy of Sciences 117 (21), 11667-11673, 2020 | 76 | 2020 |
| SiglecF (HI) marks late‐stage neutrophils of the infarcted heart: a single‐cell transcriptomic analysis of neutrophil diversification DM Calcagno, C Zhang, A Toomu, K Huang, VK Ninh, S Miyamoto, ... Journal of the American Heart Association 10 (4), e019019, 2021 | 75 | 2021 |
| Fabrication of vascularized tissue using microfabricated two-dimensional molds JP Vacanti, YMM Shin, J Ogilvie, A Sevy, T Maemura, O Ishii, ... US Patent 8,642,336, 2014 | 67 | 2014 |
